Evidence map›Paper›PMID 24900736›Full record

ArticleACS medicinal chemistry letters2013

Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release.

Claudio Battilocchio, Lucie Guetzoyan, Chiara Cervetto, Lorenzo Di Cesare Mannelli, Daniela Frattaroli, Ian R Baxendale, Guido Maura, Antonietta Rossi, Lidia Sautebin, Mariangela Biava and 3 more

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Claudio BattilocchioInnovative Technology Centre, Department of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW, United Kingdom.
Lucie GuetzoyanInnovative Technology Centre, Department of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW, United Kingdom.
Chiara CervettoDipartimento di Farmacia, Sezione di Farmacologia e Tossicologia, Universita'di Genova , Viale Cembrano 4, 16148 Genova, Italy.
Lorenzo Di Cesare MannelliDipartimento di Neuroscienze, Psicologia Area del Farmaco e Salute del Bambino, Universita' di Firenze , Viale G. Pieraccini 6, 50139 Firenze, Italy.
Daniela FrattaroliDipartimento di Farmacia, Sezione di Farmacologia e Tossicologia, Universita'di Genova , Viale Cembrano 4, 16148 Genova, Italy.
Ian R BaxendaleDepartment of Chemistry, Durham University , South Road, DH1 3LE Durham, United Kingdom.
Guido MauraDipartimento di Farmacia, Sezione di Farmacologia e Tossicologia, Universita'di Genova , Viale Cembrano 4, 16148 Genova, Italy ; Center of Excellence for Biomedical Research, Universita' di Genova , Viale Benedetto XV 5, 16132 Genova, Italy.
Antonietta RossiDipartimento di Farmacologia Sperimentale, Universita' di Napoli "Federico II" , Via D. Montesano 49, 80131 Napoli, Italy.
Lidia SautebinDipartimento di Farmacologia Sperimentale, Universita' di Napoli "Federico II" , Via D. Montesano 49, 80131 Napoli, Italy.
Mariangela BiavaDipartmento di Chimica e Tecnologie del Farmaco, Sapienza Universita' di Roma , P.le A. Moro 5, 00185 Rome, Italy.
Carla GhelardiniDipartimento di Neuroscienze, Psicologia Area del Farmaco e Salute del Bambino, Universita' di Firenze , Viale G. Pieraccini 6, 50139 Firenze, Italy.
Manuela MarcoliDipartimento di Farmacia, Sezione di Farmacologia e Tossicologia, Universita'di Genova , Viale Cembrano 4, 16148 Genova, Italy ; Center of Excellence for Biomedical Research, Universita' di Genova , Viale Benedetto XV 5, 16132 Genova, Italy.
Steven V LeyInnovative Technology Centre, Department of Chemistry, University of Cambridge , Lensfield Road, CB2 1EW, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the biological evaluation of a class of adamantane derivatives, which were achieved via modified telescoped machine-assisted flow procedure. Among the series of compounds tested in this work, 5 demonstrated outstanding analgesic properties. This compound showed that its action was not mediated through direct interaction with opioid and/or cannabinoid receptors. Moreover, it did not display any significant anti-inflammatory properties. Experiments carried out on rat cerebrocortical purified synaptosomes indicated that 5 inhibits the P2X7-evoked glutamate release, which may contribute to its antinociceptive properties. Nevertheless, further experiments are ongoing to characterize the pharmacological properties and mechanism of action of this molecule.

Indexed as

2-aminoadamantane-2-carboxylic acidAdamantane derivativesanalgesic agentsflow chemistrypurinergic receptors

Identifiers

PMID24900736
PMCPMC4027228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.